title: [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK].
abstract: We examined ten convalescent cases of local progression digestive organ cancer, which required a radical operation after a 2-week administration of preoperative dosage of PSK. Because adjuvant chemotherapy was performed for all of the cases, 3 out of 5 advanced gastric cancer patients and 4 out of 5 advanced colorectal cancer patients had more than 5-year survival. We might be effective in controlling a host immune compromise for the lap art period, which was our aim, how long preoperative PSK dosage has contributed for the extension of survival duration. We also examined the influence of the dosage in this study in preoperational of PSK, which gave a host immune compromise by the operational aggression so far, and we reported it as well.
authors.affiliation: Department of Surgery, Toho University Sakura Medical Center.
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Ooshiro
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Kitahara
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Takagi
authors.forename: Ayako
authors.initials: A
authors.lastname: Moriyama
authors.forename: Tasuku
authors.initials: T
authors.lastname: Urita
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Tanaka
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Nihonyanagi
authors.forename: Yuui
authors.initials: Y
authors.lastname: Sugishita
authors.forename: Takashi
authors.initials: T
authors.lastname: Oshiro
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kinoshita
authors.forename: Makoto
authors.initials: M
authors.lastname: Nagashima
authors.forename: Youngjin
authors.initials: Y
authors.lastname: Park
authors.forename: Shinichi
authors.initials: S
authors.lastname: Okazumi
authors.forename: Ryoji
authors.initials: R
authors.lastname: Katoh
mesh_terms: D000368:Aged; D015179:Colorectal Neoplasms / Q000401:mortality / Q000628:therapy; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000276:immunology / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D011509:Proteoglycans / Q000008:administration & dosage*; D013274:Stomach Neoplasms / Q000401:mortality / Q000628:therapy; D015996:Survival Rate
chemical_list: D007155:Immunologic Factors; D011509:Proteoglycans; C010770:polysaccharide-K